Xylem (NYSE:XYL) Price Target Raised to $164.00

Xylem (NYSE:XYL) had its price objective raised by Royal Bank Of Canada from $159.00 to $164.00 in a research report sent to investors on Wednesday morning,Benzinga reports. They currently have an outperform rating on the industrial products company’s stock.

A number of other brokerages have also weighed in on XYL. Weiss Ratings lowered Xylem from a “hold (c+)” rating to a “hold (c)” rating in a report on Friday, May 8th. CLSA upgraded shares of Xylem to a “hold” rating in a research report on Thursday, June 25th. Mizuho upped their price target on shares of Xylem from $124.00 to $130.00 and gave the stock a “neutral” rating in a research note on Wednesday. JPMorgan Chase & Co. cut their price target on shares of Xylem from $170.00 to $160.00 and set an “overweight” rating for the company in a report on Thursday, April 16th. Finally, Barclays raised their price objective on shares of Xylem from $154.00 to $159.00 and gave the company an “overweight” rating in a research note on Wednesday. Nine analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $154.00.

Xylem Price Performance

Shares of NYSE:XYL opened at $117.29 on Wednesday. Xylem has a 52 week low of $105.29 and a 52 week high of $154.27. The company has a 50-day moving average price of $115.23 and a 200 day moving average price of $122.12. The company has a market cap of $27.38 billion, a P/E ratio of 27.93, a PEG ratio of 1.62 and a beta of 1.03. The company has a quick ratio of 1.10, a current ratio of 1.61 and a debt-to-equity ratio of 0.23.

Xylem (NYSE:XYL) last released its earnings results on Tuesday, July 28th. The industrial products company reported $1.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.34 by $0.12. The company had revenue of $2.34 billion for the quarter, compared to analysts’ expectations of $2.34 billion. Xylem had a return on equity of 11.77% and a net margin of 11.15%.The firm’s quarterly revenue was up 1.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.26 EPS. Xylem has set its FY 2026 guidance at 5.550-5.700 EPS. Research analysts predict that Xylem will post 5.67 earnings per share for the current year.

Xylem Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, June 25th. Shareholders of record on Thursday, May 28th were issued a $0.43 dividend. The ex-dividend date was Thursday, May 28th. This represents a $1.72 annualized dividend and a yield of 1.5%. Xylem’s payout ratio is 40.95%.

Insiders Place Their Bets

In other Xylem news, Director Jerome A. Peribere acquired 1,210 shares of the stock in a transaction dated Monday, May 4th. The stock was acquired at an average price of $116.61 per share, with a total value of $141,098.10. Following the completion of the transaction, the director directly owned 27,209 shares in the company, valued at approximately $3,172,841.49. This trade represents a 4.65% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CAO Geri-Michelle Mcshane sold 4,269 shares of the firm’s stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $117.46, for a total value of $501,436.74. Following the completion of the sale, the chief accounting officer directly owned 3,605 shares in the company, valued at approximately $423,443.30. The trade was a 54.22% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Corporate insiders own 0.32% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the stock. Callahan Advisors LLC purchased a new position in shares of Xylem in the 4th quarter worth about $1,721,000. Northwestern Mutual Wealth Management Co. grew its holdings in shares of Xylem by 2,309.7% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 431,824 shares of the industrial products company’s stock worth $54,314,000 after purchasing an additional 413,904 shares during the period. Abacus Wealth Partners LLC purchased a new stake in shares of Xylem during the 4th quarter worth about $1,663,000. Norges Bank acquired a new stake in Xylem during the 4th quarter worth approximately $361,012,000. Finally, MUFG Securities EMEA plc increased its position in Xylem by 608.1% during the 4th quarter. MUFG Securities EMEA plc now owns 32,990 shares of the industrial products company’s stock worth $4,493,000 after purchasing an additional 28,331 shares in the last quarter. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.